The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer

Background: Cabazitaxel is a second-generation taxane that is approved for use with concomitant low dose daily prednisone in metastatic castration resistant prostate cancer (mCRPC) after docetaxel failure. Since the role of daily corticosteroids in improving cabazitaxel efficacy or ameliorating its...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cancer
Hlavní autoři: Buonerba, Carlo, Sonpavde, Guru, Vitrone, Francesca, Bosso, Davide, Puglia, Livio, Izzo, Michela, Iaccarino, Simona, Scafuri, Luca, Muratore, Margherita, Foschini, Francesca, Mucci, Brigitta, Tortora, Vincenzo, Pagliuca, Martina, Ribera, Dario, Riccio, Vittorio, Morra, Rocco, Mosca, Mirta, Cesarano, Nicola, Di Costanzo, Ileana, De Placido, Sabino, Di Lorenzo, Giuseppe
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5604196/
https://ncbi.nlm.nih.gov/pubmed/28928853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.20040
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky